Eli Lilly and AbCellera partner up on COVID-19 drugs

CNBC's Meg Tirrell speaks with Daniel M. Skovronsky, chief scientific officer at Eli Lilly, about drug company's partnership with Abcellera on COVID-19 treatment as the coronavirus outbreak spreads in the United States and Europe.

For access to live and exclusive video from CNBC subscribe to CNBC PRO: www.cnbc.com/pro/?__source=youtube

» Subscribe to CNBC TV: cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: www.cnbc.com/
Follow CNBC on LinkedIn: cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook:
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Instagram: cnb.cx/InstagramCNBC

#CNBC
#CNBC TV